Vertex Pharmaceuticals (VRTX) Shareholder's Equity Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.29% |
| Dec 31, 2025 | 10.29% |
| Sep 30, 2025 | 9.95% |
| Jun 30, 2025 | 12.90% |
| Mar 31, 2025 | 14.79% |
| Dec 31, 2024 | 17.56% |
| Sep 30, 2024 | 17.93% |
| Jun 30, 2024 | 17.12% |
| Mar 31, 2024 | 27.35% |
| Dec 31, 2023 | 26.49% |
| Sep 30, 2023 | 26.62% |
| Jun 30, 2023 | 27.19% |
| Mar 31, 2023 | 30.72% |
| Dec 31, 2022 | 31.74% |
| Sep 30, 2022 | 35.36% |
| Jun 30, 2022 | 33.02% |
| Mar 31, 2022 | 32.18% |
| Dec 31, 2021 | 31.56% |
| Sep 30, 2021 | 48.09% |
| Jun 30, 2021 | 50.18% |
| Mar 31, 2021 | 54.59% |
| Dec 31, 2020 | 62.02% |
| Sep 30, 2020 | 65.22% |
| Jun 30, 2020 | 59.10% |
| Mar 31, 2020 | 56.59% |
| Dec 31, 2019 | 65.67% |
| Sep 30, 2019 | 63.21% |
| Jun 30, 2019 | 63.09% |
| Mar 31, 2019 | 61.75% |
| Dec 31, 2018 | 59.47% |
| Sep 30, 2018 | 39.68% |
| Jun 30, 2018 | 37.33% |
| Mar 31, 2018 | 34.57% |
| Dec 31, 2017 | 23.05% |
| Sep 30, 2017 | 15.98% |
| Jun 30, 2017 | 16.79% |
| Mar 31, 2017 | 10.99% |
| Dec 31, 2016 | -0.45% |
| Sep 30, 2016 | -5.83% |
| Jun 30, 2016 | -8.17% |
| Mar 31, 2016 | 5.97% |
| Dec 31, 2015 | -2.93% |
| Sep 30, 2015 | -4.25% |
| Jun 30, 2015 | -4.56% |
| Mar 31, 2015 | -2.25% |
| Dec 31, 2014 | 5.69% |
| Sep 30, 2014 | 18.53% |
| Mar 31, 2014 | 46.48% |
| Dec 31, 2013 | 39.10% |
| Sep 30, 2013 | 30.57% |
| Jun 30, 2013 | 22.20% |
| Mar 31, 2013 | -1.80% |
| Dec 31, 2012 | 2.94% |